Skip to main content

Clinical Sites

Clinical Sites

Reading Centers

Alabama

  • University of Alabama at Birmingham

    Mark Dransfield, MD
    Mark T. Dransfield, MD
    Principal Investigator
    Our current approach to the clinical management of COPD is focused on the treatment of moderate to severe disease. To truly bend the needle in reducing morbidity and mortality we need to focus on the prevention and treatment of pre-COPD and mild disease. The SOURCE early COPD study will provide critical information about the beginnings of COPD that will facilitate that shift.
    Placeholder
    Sonya Hardy
    Clinical Study Coordinator
    (205) 934-6685
    Site Contact Information
    itis-lhc@uab.edu
    205-934-5555

California

  • University of California at Los Angeles

    Igor Barjaktarevic, MD, PhD
    Igor Barjaktarevic, MD, PhD
    Principal Investigator
    The SOURCE study’s focus on the early development of COPD and comprehensive, longitudinal assessment of future participants offers a unique opportunity to answer many important questions related to the pathogenesis of COPD. I will be honored and happy to contribute to a successful study build up.
    Roslynn McGill
    Roslynn Marzan-McGill, CPT, CCRP
    Staff Research Associate
    rmcgill@mednet.ucla.edu
    (310)825-2616
    Site Contact Information
    rmcgill@mednet.ucla.edu
    (310) 825-2616
  • University of California at San Francisco

    Prescott G. Woodruff, MD, MPH
    Prescott G. Woodruff, MD, MPH
    Principal Investigator
    Understanding how some people who are 'at risk' go on to develop COPD is a crucial step in preventing COPD.
    Placeholder
    Jennipher Jose
    Clinical Research Coordinator
    (415)476-1000
    Site Contact Information
    source@ucsf.edu
    (415) 476-3370

North Carolina

  • Wake Forest Baptist Health

    Stephen Peters, MD
    Stephen Peters, MD, PhD, FAAAAI, FACP
    Principal Investigator
    The SOURCE program represents a unique opportunity to define important factors which predispose some people to develop COPD. This is an important step in decreasing the devastating consequences of this disease.
    Marissa Millard
    Marissa Millard
    Clinical Research Coordinator
    (336)713-9190
    Site Contact Information
    mmillard@wakehealth.edu
    (336) 713-8550

Michigan

  • University of Michigan

    SOURCE study principal investigator MeiLan Han, MD, MS
    MeiLan Han, MD, MS
    Principal Investigator
    The COVID-19 pandemic has made the world more aware of the importance of lung health than ever. This study offers participants an opportunity to better understand their own lung health and for researchers to better understand factors that contribute to lung health and disease.
    Crystal Cutlip Portrait
    Crystal Cutlip
    Clinical Research Coordinator
    (734)647-6399
    Site Contact Information
    ccutlip@med.umich.edu
    (734) 647-6399

Utah

  • University of Utah Lung Health Research Center

    Robert Paine III, MD
    Robert Paine III, MD
    Principal Investigator
    Martin Villegas
    Martin Villegas
    Clinical Research Program Manager
    (801) 581-6496
    Site Contact Information
    mvillegas@hsc.utah.edu
    (801) 581-6496

New York

  • Columbia University Medical Center

    Photo of Barr
    R. Graham Barr, MD, PhD
    Principal Investigator
    Michael Sheffey
    Michael Sheffey
    Project Coordinator
    (347) 835- 8180
    Site Contact Information
    ms5394@cumc.columbia.edu
    (347) 835-8180

Maryland

  • Johns Hopkins Bayview Medical Center

    Nadia Hansel, MD, MPH
    Nadia Hansel, MD, MPH
    Principal Investigator
    Cheryl Clare
    Cheryl Clare
    Clinical Research Coordinator
    Site Contact Information
    cdaniel9@jhu.edu
    (410) 550-2864

Colorado

  • National Jewish Health

    Russell Bowler
    Russell Bowler, MD, PhD
    Principal Investigator
    COPD is a leading cause of death among smokers, yet we know little about the origins of early COPD. Your participation in the source study will help us understand which smokers are at risk of progression to COPD and the factors that increase this risk.
    Alex M. Jones
    Alex M. Jones, MSW
    Clinical Research Coordinator
    (303)398-1943
    Site Contact Information
    jonesa@njhealth.org
    (303) 398-1943

Pennsylvania

  • Temple University

    Gerard Criner, MD
    Gerard Criner, MD, FACP, FACCP
    Principal Investigator
    COPD is a devastating disease of significant morbidity and mortality for many patients worldwide. Identifying the origins of COPD is pivotal to help develop novel targets for early treatment to improve patient outcome.
    Placeholder
    Melissa Liverpool
    Clinical Research Coordinator
    Site Contact Information
    breathe@tuhs.temple.edu
    (215) 707-1359

Illinois

  • University of Illinois at Chicago

    Jerry Krishnan, MD, PhD
    Jerry Krishnan, MD, PhD
    Principal Investigator
    We know that some younger cigarette smokers are diagnosed with COPD while others may smoke for years without developing COPD. This study will shed light on what contributes to such different outcomes and will help me explain to my patients whether they are at risk for COPD.
    Placeholder
    Tabitha C
    Clinical Research Coordinator
    source_study@uic.edu
    (312) 996-1365
    Site Contact Information
    source_study@uic.edu
    (312) 996-1365

Iowa

  • University of Iowa Hospitals and Clinics

    Alejandro Comellas, MD
    Alejandro Comellas, MD
    Principal Investigator
    Chronic lung diseases have an incredible impact on general health and quality of life. COPD is a common problem worldwide, which affects all races and genders. This study provides us with the opportunity to better understand factors that affect lung health and potentially develop future therapeutic strategies to change the course of the disease.
    Placeholder
    Mike Wurth
    Clinical Trials Research Assistant
    (319) 356-1785
    Site Contact Information
    mike-wurth@uiowa.edu
    (319) 356-1785